The International Journal of Gynecological Cancer publishes content on novel and relevant topics in the field of gynecologic cancer. IJGC Podcast features short interview segments with leading experts discussing the latest research in their respective areas. The podcasts will serve as an interactive and education experience for all our listeners. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Robotic vs Open Radical Hysterectomy: Pathology Interrogation with Javier Magrina
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Javier Magrina to discuss robotic vs open radical hysterectomy in pathology interrogation. Dr. Magrina is a Professor of Obstetrics and Gynecology at Mayo Graduate School of Medicine, and the recipient of the Barbara Woodward Lips Professorship. He is a staff consultant at Mayo Clinic Arizona.
. robotic radical hysterectomy results in inferior survival as compared to laparotomy.
. robotic radical hysterectomy for early cervical cancer . intraperitoneal recurrences are not seen with laparotomy and appear due to the exfoliation and seeding of cervical cancer cells.
Psychosexual Morbidity in Women with Ovarian Cancer with Julia Pugh and Chloe Logue
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Julia Pugh and Chloe Logue to discuss psychosexual morbidity in women with ovarian cancer. Dr. Julia Pugh is a Gynaecology Clinical Nurse Specialist and psychosexual therapist based at The Christie Hospital in Manchester, UK. Dr. Pugh completed her Advanced Nursing Practice Masters at the University of Manchester and offers support for psychosexual concerns of men and women with cancer. Dr. Chloe Logue is a practicing junior doctor in Manchester. She completed her academic foundation at the Christie Cancer Hospital in Gynaecological Oncology, supervised by Prof Gordon Jayson.
- 75% of women with ovarian cancer experience psychosexual morbidity, exceeding published general population values.
- Key potential risk factors are: younger age, premenopausal status at diagnosis, extensive surgery, more courses of chemotherapy, cardiovascular co-morbidities and anxiety and depression.
- Common presenting symptoms include: vaginal dryness (81-87%) and pain (77%), amongst reduced sexual desire and activity, impaired orgasm, diminished perceived body image and reduced partner intimacy.
- The review identified that psychosexual issues are not routinely discussed nor adequately managed by clinicians. Psychosexual problems remain a priority for many women with ovarian cancer, many symptoms could be addressed by discussing their concerns and simple physical measures.
Reviewing the November Issue with Florencia Noll (Spanish Version)
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the November issue of IJGC in Spanish.
Outcomes of Ultra-radical Surgery in Ovarian Cancer with Sahar Salehi
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Sr. Sahar Salehi to discuss outcomes of ultra-radical surgery in ovarian cancer. Dr. Salehi is the Director of ovarian cancer surgery at Karolinska University Hospital, in Stockholm, Sweden, as well as an Assistant Professor at the Department of Microbiology, Tumor and Cellbiology at Karolinska Institutet.
• A shift to ultra-radical surgery does not improve survival despite increased complete resection rates, for this reason complete resection may not be the absolute aim in a high surgical proficiency setting.
• A shift to ultra-radical surgery increase the proportion of non-surgically treated women.
• The majority of women with cancer in the abdomen of unknown origin (inoperabel/non-resectable women/women who might not meet a gynecologic oncologist) are ovarian cancer patients.
• There is an urgent need to calibrate selection of patients to surgery (and to which extent of surgery) in more detail.
Reviewing the November Issue with Sadie Jones and Navya Nair (English Version)
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the November issue of IJGC.
Results of the SCORPION Trial with Anna Fagotti
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti to discuss the results of the SCORPION trial. Dr. Fagotti is the lead author of "Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)", which is the Lead Article of IJGC’s November 2020 issue (https://ijgc.bmj.com/content/early/2020/10/07/ijgc-2020-001640).
Dr. Fagotti is the Ovarian Cancer Unit Director at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy, as well as an Associate Professor of Obstetrics and Gynecology at Università Cattolica del Sacro Cuore. Additionally, she is PhD Faculty of Biotechnology at University of Perugia, ESGO Council Member and Chair of the Educational Committee, as well as an Associate Editor for IJGC.
1. PDS and NACT ± IDS have superimposable median PFS and OS in patients with HTL ovarian cancer.
2. PDS has a higher rate of postoperative complications than IDS.
3. RT is the most powerful prognostic factor in AOC patients both at PDS and IDS"
Customer ReviewsSee All
Gyn Onc Podcast
This is wonderful. I appreciate having the opportunity to listen to experts discuss their research while I’m commuting or out for a walk. Thanks for doing it.